Search Within

Nivetha Ganesan

Formats
  1. Meeting Abstract (41)
  2. Journal Article (12)
  3. Research Letter (1)
Groups
  1. Center for Hematologic Malignancies (53)
  2. Department of Medicine (53)
  3. Hematologic Malignancies, Division of (53)
  4. Lymphoma (53)
  5. Population Sciences Research Program (46)
  6. Hematology-Oncology Fellows (34)

More Groups

People
  1. Steven Horwitz (46)
  2. Alison Moskowitz (43)
  3. Natasha Galasso (35)
  4. Ahmet Dogan (27)
  5. Paola Ghione (27)
  6. Ariela Noy (26)

More People

Years
  1. 2025 (1)
  2. 2024 (12)
  3. 2023 (15)
  4. 2022 (5)
  5. 2021 (9)
  6. 2020 (5)

More Years

Publications
  1. Blood (33)
  2. Hematological Oncology (5)
  3. Journal of Clinical Oncology (5)
  4. Blood Advances (3)
  5. American Journal of Hematology (1)
  6. Cancer Research (1)

More Publications

Publishers
  1. American Society of Hematology (36)
  2. American Society of Clinical Oncology (5)
  3. Wiley Blackwell (5)
  4. American Association for Cancer Research (1)
  5. American Association for the Advancement of Science (1)
  6. Elsevier Science, Inc. (1)

More Publishers

Results (54)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Emapalumab for malignancy-associated hemophagocytic lymphohistiocytosis: The Memorial Sloan Kettering Cancer Center experience
    Meeting Abstract

    Johnson, W. T.; Epstein-Peterson, Z. D.; Ganesan, N.; Chang, T.; Galasso, N.; Stuver, R.; Khan, N.; Salles, G.; Moskowitz, A. J.; Vardhana, S.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • CNS relapse in T-cell lymphoma index: A risk score to predict central nervous system relapse in patients with T-cell lymphomas
    Meeting Abstract

    Bhansali, R. S.; Ellin, F.; Cao, M.; Relander, T.; Li, W.; Long, Q.; Ganesan, N.; Stuver, R.; Horwitz, S. M.; Wudhikarn, K.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Impact of bone marrow involvement in patients with peripheral T-cell lymphoma undergoing autologous stem cell transplant
    Meeting Abstract

    Stuver, R.; Mazloom, A.; Ganesan, N.; Horwitz, S. M.; Moskowitz, A. J.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Quantitative change in metabolic tumor volume may assist in distinguishing between pseudoprogressors and responders in patients with relapsed/refractory classical Hodgkin lymphoma treated with PD-1 blockade
    Meeting Abstract

    Wills, B.; Michaud, L.; Schòˆder, H.; Ganesan, N.; Moskowitz, C. H.; Straus, D. J.; Falchi, L.; Matasar, M. J.; Zelenetz, A. D.; Joffe, E.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • TP53 mutations identify high-risk peripheral T-cell lymphoma patients treated with CHOP-based chemotherapy
    Meeting Abstract

    Johnson, W. T.; Ganesan, N.; Epstein-Peterson, Z. D.; Maccaro, C.; Galasso, N.; Sauter, C. S.; Neuman, R.; Khan, N.; Moskowitz, A. J.; Dogan, A.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • A multi-institutional retrospective analysis of T-cell lymphomas with central nervous system relapse
    Meeting Abstract

    Bhansali, R. S.; Ganesan, N.; Stuver, R. N.; Horwitz, S. M.; Wudhikarn, K.; Hwang, S. R.; Bennani, N.; Chavez, J. C.; Sokol, L.; Saeed, H.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • A phase 2 biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK/STAT targeting in T-cell lymphomas
    Journal Article

    Moskowitz, A. J.; Ghione, P.; Jacobsen, E.; Ruan, J.; Schatz, J. H.; Noor, S.; Myskowski, P.; Vardhana, S.; Ganesan, N.; Hancock, H.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Phase II trial of pembrolizumab plus gemcitabine, vinorelbine, and liposomal doxorubicin as second-line therapy for relapsed or refractory classical Hodgkin lymphoma
    Journal Article

    Moskowitz, A. J.; Shah, G.; Schòˆder, H.; Ganesan, N.; Drill, E.; Hancock, H.; Davey, T.; Perez, L.; Ryu, S.; Sohail, S.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Outcomes of adult T-cell leukemia/lymphoma with allogeneic stem cell transplantation: Single-institution experience
    Journal Article

    Epstein-Peterson, Z. D.; Ganesan, N.; Barker, J. N.; Drullinsky, P. R.; Ghione, P.; Jakubowski, A. A.; Kumar, A.; Moskowitz, A. J.; Noy, A.; Perales, M. A.; more...
    Leukemia and Lymphoma (2021)

    Fulltext@MSK | Save
  • Romidepsin and lenalidomide-based regimens have efficacy in relapsed/refractory lymphoma: Combined analysis of two phase I studies with expansion cohorts
    Journal Article

    Mehta-Shah, N.; Lunning, M. A.; Moskowitz, A. J.; Boruchov, A. M.; Ruan, J.; Lynch, P.; Hamlin, P. A.; Leonard, J.; Matasar, M. J.; Myskowski, P. L.; more...
    American Journal of Hematology (2021)

    Fulltext@MSK | Save